The Application of Kinesio Taping Technique in the Early Upper Limb Functional Activities Induction of Hemiplegic Patients After Stroke

NCT06834750 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2025-03-21

No results posted yet for this study

Summary

1. To observe the inducing and promoting effect of kinesio taping technique on the recovery of upper limb function in early-stage stroke patients.
2. To compare the different effects of kinesio tape and sports white tape on the induction and promotion of limb function in patients.
3. To verify that kinesio taping technique is a safe and promotable technical means for stroke patients.

Conditions

  • Cerebral Infarction Recovery
  • Rehabilitation Treatment
  • Upper Extremity Motor Function
  • Emg Biofeedback

Interventions

OTHER

Experimental Group

The application methods of kinesiology tape for the experimental group are as follows: 1. Promoting supraspinatus muscle: Use an I-shaped tape (with natural tension). 2. Promoting the anterior fibers of the deltoid muscle: Use an I-shaped tape (with natural tension). 3. Promoting the posterior fibers of the deltoid muscle: Use an I-shaped tape (with natural tension).3. Promoting the posterior fibers of the deltoid muscle: Use an I-shaped tape (with natural tension). 4. Fixing the shoulder joint: Use an I-shaped tape (with moderate tension). 5. Inhibiting biceps brachii muscle / promoting triceps brachii muscle (depending on the patient's recovery stage and different functional impairments, different taping methods are used). 6. Promoting wrist extensor muscles / inhibiting wrist flexor muscles (depending on the patient's recovery stage and different functional impairments, different taping methods are used)

OTHER

Control group (placebo)

The control group was pasted with sports white tape (the pasting method was the same as above, replaced with sports white tape).

Sponsors & Collaborators

  • The Fourth Affiliated Hospital of Zhejiang University School of Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2026-01-01
Completion
2026-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06834750 on ClinicalTrials.gov